Brain Cancer News

Organization leads state legislative efforts, champions cancer research, and secures funding to advance the future of oncology and develop tomorrow’s leaders.

In The Conversation, Christiano Marconi discusses a new study in Nature finding that the COVID-19 mRNA vaccine sparks an immune response to fight cancer.

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, MBI researchers have found.

See highlights stemming from paper published in the journal Nature BME on July 18.

Drs. Jianping Huang and John Ligon have launched a human clinical trial to test an immunotherapy treatment for children with high-grade gliomas.

An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine.

Dr. Elias Sayour describes his groundbreaking research to find new treatments for glioblastoma for Inside Precision Medicine.

Groundbreaking study showing fierce immune response to fight malignant brain tumor featured in The Economist.

Dr. Elias Sayour earns honor from UF Innovate | Tech Licensing for his work in brain cancer immunotherapy.

Dr. Elias Sayour was featured for UF Innovate’s Tech Tuesday, discussing his work to develop mRNA brain cancer vaccines.